Similarly, in murine models, sTIM3 reduced anti-tumor cytotoxic T lymphocyte activity, the number of TILs, and the expression of Th1 cytokines IL-2, IFN-γ, and TNF-β [146]. The gene discussed is IL2; the disease is neoplasm.